Recent Updates
Recently added Catalysts
VTRS Positive Sentiment Score: 70/100

Viatris to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 Viatris Inc. (NASDAQ: VTRS) will report financial results for the fourth quarter and full year 2024 on Thursday, February 27, 2025. Company...

Key Takeaway: Viatris Inc. (NASDAQ: VTRS) is scheduled to report its financial results for the fourth quarter and full year of 2024 on February 27, 2025. A live webcast will be hosted by company executives at 8:30 a.m. ET on the same day, allowing investors and the public to engage with the results. The webcast will also have a replay available later on the company's website. Viatris continues to serve approximately 1 billion patients annually with its diverse portfolio of medicines.

Market Sentiment Analysis

POSITIVE FACTORS

  • Viatris is set to report promising financial results for Q4 and full year 2024.
  • The company will provide a live webcast for investors, enhancing transparency.
  • Viatris has a strong mission focusing on empowering global health.

Full Press Release Details

PITTSBURGH , Feb. 3, 2025 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS ) will report financial results for the fourth quarter and full year 2024 on Thursday, February 27, 2025 . Company executives will host a webcast at 8:30 a.m. ET on the same date to discuss the results.
Investors and the general public are invited to listen to a live webcast of the call at investor.viatris.com or by calling 844.308.3344 or 412.317.1896 for international callers. A replay of the webcast also will be available on the website.
About Viatris Viatris Inc . (NASDAQ: VTRS ) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris. We are headquartered in the U.S., with global centers in Pittsburgh , Shanghai and Hyderabad, India . Learn more at viatris.com and investor.viatris.com , and connect with us on LinkedIn , Instagram , YouTube and X .
SOURCE Viatris Inc.

21 %

About Viatris Inc.

Ticker Symbol: VTRS
Exchange: NASDAQ
Mission: Empower people worldwide to live healthier at every stage of life
Patient Reach: ~1 billion patients annually
Global Centers: Pittsburgh, Shanghai, Hyderabad

Frequently Asked Questions

When will Viatris report its 2024 financial results?

Viatris will report its financial results on February 27, 2025.

How can I listen to the Viatris earnings call?

You can listen via webcast at investor.viatris.com or call 844.308.3344.

What is the mission of Viatris Inc.?

Viatris aims to empower global health access at every life stage.

Where is Viatris headquartered?

Viatris is headquartered in the U.S., with global centers in Pittsburgh, Shanghai, and Hyderabad.

How many patients does Viatris supply medicines to annually?

Viatris supplies high-quality medicines to around 1 billion patients each year.

Last updated: Feb 3, 2025